Related references
Note: Only part of the references are listed.The evolution paths of some reprehensive scaffolds of RORγt modulators, a perspective from medicinal chemistry
Zhuohao Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Discovery of tetrahydroquinolines and benzomorpholines as novel potent RORγt agonists
Yuehan Xia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists
Nannan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of N-indanyl benzamides as potent RORγt inverse agonists
Jinlong Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of carbazole carboxamides as novel RORγt inverse agonists
Yafei Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
RORγ antagonists and inverse agonists: a patent review
Sarah M. Bronner et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
NATURE IMMUNOLOGY (2017)
Recent progress on nuclear receptor RORγ modulators
Patrick Cyr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis
Xiaohua Xue et al.
SCIENTIFIC REPORTS (2016)
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
Benjamin Farahnik et al.
DERMATOLOGY AND THERAPY (2016)
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
Yonghui Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The IL-23-IL-17 axis in inflammatory arthritis
Erik Lubberts
NATURE REVIEWS RHEUMATOLOGY (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
ROR nuclear receptors: structures, related diseases, and drug discovery
Yan Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl) amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors
Yonghui Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
Khalifa El Malki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
Transcriptional regulatory networks in Th17 cell differentiation
Liang Zhou et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
Nicolas Manel et al.
NATURE IMMUNOLOGY (2008)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Share Paper
